Mereo BioPharma Group plc is a clinical-stage biopharmaceutical company based in Redwood City, CA, dedicated to improving the lives of patients with rare diseases through the development of revolutionary therapies. With a focus on identifying and developing therapies with significant long-term potential, Mereo is committed to unlocking new possibilities in the treatment of rare diseases.
The company's pipeline includes promising treatments such as setrusumab, alvelestat, and etigilimab, with recent updates showcasing positive results and advancements in their mission to address unmet medical needs. Through collaborations with healthcare professionals, patient communities, and investor partnerships, Mereo BioPharma is at the forefront of innovation in the biopharmaceutical industry.
Generated from the website